✦ LIBER ✦

The use of flutamide as a single antiandrogen treatment for hormone-refractory prostate cancer

✍ Scribed by W.R. Pitts Jr

Book ID: 109051515
Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 123 KB
Volume: 93
Category: Article
ISSN: 1464-4096
DOI: 10.1111/j.1464-410x.2004.4834j.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The use of flutamide in hormone-refracto

The use of flutamide in hormone-refractory metastatic prostate cancer

✍ D. G. McLeod; R. C. Benson Jr; M. A. Eisenberger; E. D. Crawford; B. A. Blumenst 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 444 KB 👁 2 views

Clinical outcome of maximum androgen blo

Clinical outcome of maximum androgen blockade using flutamide as second-line hormonal therapy for hormone-refractory prostate cancer

✍ Hideaki Miyake; Isao Hara; Hiroshi Eto 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB

Effects of flutamide as a second-line ag

Effects of flutamide as a second-line agent for maximum androgen blockade of hormone refractory prostate cancer

✍ Kenji Nishimura; Naoko Arichi; Shigeki Tokugawa; Iwao Yoshioka; Hidefumi Kishika 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB

Antitumor activity of suramin in hormone

Antitumor activity of suramin in hormone-refractory prostate cancer controlling for hydrocortisone treatment and flutamide withdrawal as potentially confounding variables

✍ Nancy A. Dawson; Michael R. Cooper; William D. Figg; Donna J. Headlee; Alain Thi 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 965 KB

Phase II trial evaluating a docetaxel-ca

Phase II trial evaluating a docetaxel-capecitabine combination as treatment for hormone-refractory prostate cancer

✍ Jean-Marc Ferrero; Emmanuel Chamorey; Stephane Oudard; Sabine Dides; Gerard Lesb 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB

Evidence of a novel docetaxel sensitizer

Evidence of a novel docetaxel sensitizer, garlic-derived S-allylmercaptocysteine, as a treatment option for hormone refractory prostate cancer

✍ Edward W. Howard; Davy T. Lee; Yung Tuen Chiu; Chee Wai Chua; Xianghong Wang; Yo 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 French ⚖ 770 KB

## Abstract The recent introduction of docetaxel in the treatment of hormone refractory prostate cancer (HRPC) has made a small but significant impact on patient survival. However, its effect is limited by intolerance and resistance. The aim of our study was to investigate if the garlic‐derived com